Black Diamond Therapeutics Inc logo

BDTX - Black Diamond Therapeutics Inc News Story

$25.5 -0.1  -0.2%

Last Trade - 07/05/21

Sector
Healthcare
Size
Mid Cap
Market Cap £660.0m
Enterprise Value £434.5m
Revenue £n/a
Position in Universe 2925th / 6858

BRIEF-Black Diamond Therapeutics Inc Qtrly Loss Per Share $0.63

Thu 25th March, 2021 11:17am
March 25 (Reuters) - Black Diamond Therapeutics Inc
 BDTX.O :
    * QTRLY LOSS PER SHARE $0.63
    * BLACK DIAMOND THERAPEUTICS- CASH,CASH EQUIVALENTS,
INVESTMENTS
OF $315.1 MILLION AS OF DEC 31, 2020 EXPECTED TO BE SUFFICIENT
TO FUND OPERATIONS INTO 2023
    * Q4 EARNINGS PER SHARE VIEW $-0.63 -- REFINITIV IBES DATA

Source: [ID:https://bit.ly/3chetUG]
Further company coverage:  BDTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.